Cargando…
A Rare Case of Prototheca Algaemia in a Patient with Systemic Lupus Erythematosus and Recent Belimumab Infusion
Novel agents for the treatment of immune-mediated diseases such as systemic lupus erythematosus (SLE) have been increasingly used as an alternative to or in combination with conventional therapies. Belimumab, a human monoclonal antibody that inhibits B-cell activating factor (BAFF), has demonstrated...
Autores principales: | Mejia-Otero, Carolina, Singh, Shelley, Arias Urdaneta, Luis, Sesin, Carlos, Chakrabarti, Anindita, Miller, Nanci Mae, Tuda, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207598/ https://www.ncbi.nlm.nih.gov/pubmed/25374733 http://dx.doi.org/10.1155/2012/754901 |
Ejemplares similares
-
405. Outbreak of Prototheca Wickerhamii Algaemia in a Tertiary Care Chemoradiation Oncology Unit
por: Khan, Inam Danish
Publicado: (2018) -
Protothecosis algaemia in a patient presenting with septic arthritis: A rare case of Prototheca zopfii isolated from Malaysia
por: Palaniappan, Prem Ananth, et al.
Publicado: (2021) -
Belimumab in systemic lupus erythematosus
por: Vilas-Boas, Andreia, et al.
Publicado: (2015) -
Belimumab in Systemic Lupus Erythematosus
por: Srivastava, Ankita
Publicado: (2016) -
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)